Abstracts 405 citations. Two reviewers independently examined each citation and abstract. We conducted three levels of review resulting in 94 papers for full review. Data were analyzed using qualitative and quantitative methods, including a meta-analysis using a random effects model (REM) and Mantel-Haenszel (MH) summary estimate.
PCV81 MEASURING THE IMPACT OF SOCIO-DEMOGRAPHIC CHARACTERISTICS ON PATIENT PERSISTENCE IN CHRONIC MARKETS
Henderson SC 1 , Denarie MF 2 , Yuan Y 1 1 IMS Health, Blue Bell, PA, USA, 2 IMS Health, Plymouth Meeting, PA, USA OBJECTIVES: Although patient fi nances are widely studied as predictors of adherence, claims databases rarely include variables other than copay and insurance coverage. Linking personal income, level of education, and ethnicity to prescription data can enhance analyses of socioeconomic factors and adherence. We compared persistence in chronic markets -statins and oral antidiabetics (OADs) -by income, education, and ethnicity in linked administrative databases. METHODS: Using IMS' LifeLink longitudinal prescription database (LRx), linked to commercial socio-economic data, we selected 143,370 patients initiating statins and 57,079 patients initiating OADs after a minimum 12 month clean period. LRx captures 62% of prescription claims contributed by retail pharmacies in the US. Cox proportional hazards models compared persistence by income, education, ethnicity, age, and method of payment. RESULTS: Mean days of statin persistence was higher for patients with household income $75K/yr (149 days) than for patients with $40-75,000K/year household income (144 days) (p 0.001). Patients with very low income ( $K/yr) were more frequently on Medicaid or over age 65; these very low income patients had higher persistence (150 days) than patients with income of $15 $40,000/year (144 days) (p 0.005). Persistence also increased with level of education (graduate school 154 days vs. high school 147 days, p 0.001) and differed by ethnicity (Caucasian 150 days, Hispanic 127 days, African American 124 days; p 0.001). Similar trends were observed with OADs. CONCLUSIONS: Patients with higher household income demonstrate slightly improved persistence, while patients with very low income, but subsidized pharmacy benefi ts, also have higher than average persistence. Differences in persistence also are found with higher levels of education and across ethnic groups. Rapp T pp , Schneider M, Zuckerman IH T T University of Maryland, Baltimore, MD, USA OBJECTIVES: We estimated the relationship between nursing home admission and non-adherence to anti-hypertensive medications. We calculated the incremental proportion of nursing home admission that was due to non-adherence, and the annual incremental cost of the proportion of nursing home admission due to nonadherence. METHODS: We calculated adherence scores in a cohort of 225,624 subjects with hypertension from the MarketScan database. We used a generalized linear model with a binomial distribution and a log link to estimate adjusted relative risks of nursing home admission. We calculated the fraction of nursing home admission attributable to non-adherence. RESULTS: We showed that non-adherence to antihypertensive medications increases the risk of nursing home admission. Among nonadherent subjects, 10.8% were admitted to nursing homes. In the general population of community-dwelling elderly subjects, 1.9% of nursing home admissions were attributable to non-adherence to anti-hypertensive medication. Extending these results to the United States elderly (age 65) population with hypertension, we found that annually 28,372 subjects were admitted to nursing homes in 2002 because of nonadherence to anti-hypertensive medications. In 2002, the cost of nursing home admission due to non-adherence was estimated to be $1.7 billion. CONCLUSIONS: Anti-hypertensive medication non-adherence was a risk factor for elderly transitioning to long-term care facilities. Since non-adherence may be viewed as a proxy for lack of social support, our results show the potential benefi ts related to interventions that could provide social support to elderly patients, such as assistance with medication administration.
PCV82 FRACTION OF NURSING HOME ADMISSION AND INCREMENTAL COST ATTRIBUTABLE TO NON ADHERENCE TO ANTI HYPERTENSIVE MEDICATIONS

PCV83 FACTORS AFFECTING ADHERENCE TO ANTIHYPERTENSIVE MEDICATION IN A NIGERIAN POPULATION
Ekwunife OI 1 , Aguwa CN 1 , Udeogaranya PO 2 1 University of Nigeria Nsukka, Nsukka, Enugu State, Nigeria, 2 University of Nigeria Nsukka, Nsukka, Enugu, Nigeria OBJECTIVES: Poor adherence to anti-hypertensives severely compromises the effectiveness of treatment. The aim of this study was to measure adherence to antihypertensive therapy and to determine the factors that are associated with poor adherence in a sample of hypertensive patients in Nsukka, a semi urban town located in SouthEastern Nigeria. METHODS: A cross sectional, household survey was conducted in Nsukka. Adherence to antihypertensive medications was assessed on participants that were hypertensive. Patient self-reports about the number of pills taken over a prescribed period were used to estimate adherence as a percentage. In addition, Morisky Medication Adherence Scale (MMAS) was used in order to increase the strength and consistency of patient's self-report on adherence. RESULTS: A total of 756 participants were screened for hypertension. Forty-seven persons were hypertensive. Mean adherence to hypertension medication was 70.7% 37.9%. Mean adherence score was correlated to MMAS score (r 0.401, p 0.05). Educational status, making medications a habit, and experience of side effects were independently correlated to adherence. Multiple linear regression showed that for every increase in educational status, adherence increased by 12.1%. Also making medication a habit increased adherence by 35.09%. However, experience of side-effect decreased adherence by 20.1%. CONCLUSIONS: These factors identifi ed as correlates of adherence to antihypertensives in the study population could be used to design interventions to improve adherence to hypertension medications in Nigeria. A common side effect of niacin therapy is fl ushing characterized by warmth, redness, itching, and/or tingling. The FAST was developed to assess fl ushing symptoms and clinical impact on patients. This study evaluated the psychometrics and minimal important difference (MID) of the FAST. METHODS: A randomized, doubleblind, parallel group, multicenter, placebo (PBO)-controlled prospective 6-week study evaluated the FAST. 269 patients with dyslipidemia were randomized (1:1:1) to niacin extended-release (NER)/acetylsalicylic acid (ASA), NER/ASA PBO, or PBO/PBO. Patients completed the FAST electronic diary daily. RESULTS: FAST test-retest reliability during the fi rst 2 weeks among stable subjects was demonstrated for mean overall fl ushing severity using patient/physician-rated overall treatment effect (OTE) ratings (intraclass correlation coeffi cients of 0.75 and 0.76). Over the 6 week treatment
PCV86 FLUSHING ASSESSMENT TOOL (FAST): PSYCHOMETRIC PROPERTIES OF A NEW MEASURE ASSESSING FLUSHING SYMPTOMS
